DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
A Strong Dysregulated Myeloid Component in the Epigenetic Landscape of Systemic Sclerosis: An Integrated DNA Methylome and Transcriptome Analysis, Genome‐wide integrated DNA methylome and transcriptome analysis reveals a strong dysregulated myeloid component in the epigenetic landscape of Systemic Sclerosis
This research is part of the doctoral degree awarded to Dr Martínez-L opezwithin the biomedicine program from the University of Granada., [Objective] Nongenetic factors influence systemic sclerosis (SSc) pathogenesis, underscoring epigenetics as a rel-evant contributor to the disease. We aimed to unravel DNA methylation abnormalities associated with SSc through anepigenome-wide association study., [Methods] We analyzed DNA methylation data from whole-blood samples in 179 patients with SSc and 241 unaffected individuals to identify differentially methylated positions (DMPs) with a false discovery rate (FDR) <0.05. Theseresults were further integrated with RNA sequencing data from the same patients to assess their functional conse-quence. Additionally, we examined the impact of DNA methylation changes on transcription factors and analyzed therelationship between alterations of the methylation and gene expression profile and serum proteins levels, [Results] This analysis yielded 525 DMPs enriched in immune-related pathways, with leukocyte cell–cell adhesionbeing the most significant (FDR = 4.91 × 10−9 ), prioritizing integrins as they were exposed by integrating methylomeand transcriptome data. Furthermore, through this integrative approach, we observed an enrichment of neutrophil-related pathways, highlighting this myeloid cell type as a relevant contributor in SSc pathogenesis. In addition, weuncovered novel profibrotic and proinflammatory mechanisms involved in the disease. Finally, the altered epigeneticand transcriptomic signature revealed an increased activity of CCAAT/enhancer-binding protein transcription factorfamily in SSc, which is crucial in the myeloid lineage developmen, [Conclusion] Our findings uncover the impaired epigenetic regulation of the disease and its impact on gene expres-sion, identifying new molecules for potential clinical applications and improving our understanding of SSc pathogenesis, We thank Sofia Vargas and Gema Robledo for their excellent technical assistance; all members of the PRECISESADS consortium, particularly Ralf Lesche, Sepideh Babaei, Anne Buttgereit, Suzana Makowska, and Martina Runge for preparing the RNA-seq data; and Johan Frostegård and Jacques-Olivier Pers for preparing and normalizing the serum protein data. We also want to thank all the patients and control donors for their essential collaboration., Supported by the Innovative Medicines Initiative Joint Undertaking (grant115565; PRECISESADS project), resources of which are composed of financialcontribution from the European Union’s Seventh Framework Program(FP7/2007–2013) and European Federation of Pharmaceutical Industries and Associations companies’ in-kind contribution, and by Redes de Investigacion Cooperativa Orientadas a Resultados en Salud through Instituto de SaludCarlos III (ISCIII) (RD21/0002/0039). Mr Martínez-Lopez’s work was supported by a predoctoral contract in health related research (PFIS) (FI23/00231) from ISCIII. Dr Ortiz-Fernandez’s work was supported by a Ramon y Cajal fellowship (RYC2022-036635-I) funded by MICIU/AEI/10.13039/501100011033 and by ESF+. Dr Acosta-Herrera’s work was supported by a Miguel Servet fellowship (CP21/00132) from ISCIII, Peer reviewed
Project:
AEI RYC2022-036635-I
DOI: http://hdl.handle.net/10261/399535, https://api.elsevier.com/content/abstract/scopus_id/85211068824
HANDLE: http://hdl.handle.net/10261/399535, https://api.elsevier.com/content/abstract/scopus_id/85211068824